Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Background & Aims The mammalian target of rapamycin (mTOR) plays a pivotal role in hepatocellular carcinoma (HCC). Previous studies indicated that inhibition of mTORC1 enhanced histone deacetylase inhibitors (HDACis)-mediated anti-tumor activity, accompanied with feedback activation of AKT. Ther...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2012-01, Vol.56 (1), p.176-183
Hauptverfasser: Shao, Huanjie, Gao, Chun, Tang, Haikuo, Zhang, Hao, Roberts, Lewis R, Hylander, Bonnie L, Repasky, Elizabeth A, Ma, Wen W, Qiu, Jingxin, Adjei, Alex A, Dy, Grace K, Yu, Chunrong
Format: Artikel
Sprache:eng
Schlagworte:
AKT
Bim
HCC
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!